332 related articles for article (PubMed ID: 11044105)
1. Utilization of the bovine papillomavirus type 1 late-stage-specific nucleotide 3605 3' splice site is modulated by a novel exonic bipartite regulator but not by an intronic purine-rich element.
Zheng ZM; Reid ES; Baker CC
J Virol; 2000 Nov; 74(22):10612-22. PubMed ID: 11044105
[TBL] [Abstract][Full Text] [Related]
2. Selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor.
Zheng ZM; He P; Baker CC
J Virol; 1996 Jul; 70(7):4691-9. PubMed ID: 8676495
[TBL] [Abstract][Full Text] [Related]
3. Optimization of a weak 3' splice site counteracts the function of a bovine papillomavirus type 1 exonic splicing suppressor in vitro and in vivo.
Zheng ZM; Quintero J; Reid ES; Gocke C; Baker CC
J Virol; 2000 Jul; 74(13):5902-10. PubMed ID: 10846071
[TBL] [Abstract][Full Text] [Related]
4. Function of a bovine papillomavirus type 1 exonic splicing suppressor requires a suboptimal upstream 3' splice site.
Zheng ZM; He PJ; Baker CC
J Virol; 1999 Jan; 73(1):29-36. PubMed ID: 9847303
[TBL] [Abstract][Full Text] [Related]
5. Structural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancers.
Zheng ZM; He PJ; Baker CC
J Virol; 1997 Dec; 71(12):9096-107. PubMed ID: 9371566
[TBL] [Abstract][Full Text] [Related]
6. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway.
Liu X; Mayeda A; Tao M; Zheng ZM
J Virol; 2003 Feb; 77(3):2105-15. PubMed ID: 12525645
[TBL] [Abstract][Full Text] [Related]
7. A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly.
Zheng ZM; Huynen M; Baker CC
Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14088-93. PubMed ID: 9826658
[TBL] [Abstract][Full Text] [Related]
8. Control of the papillomavirus early-to-late switch by differentially expressed SRp20.
Jia R; Liu X; Tao M; Kruhlak M; Guo M; Meyers C; Baker CC; Zheng ZM
J Virol; 2009 Jan; 83(1):167-80. PubMed ID: 18945760
[TBL] [Abstract][Full Text] [Related]
9. The strength of the HIV-1 3' splice sites affects Rev function.
Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
[TBL] [Abstract][Full Text] [Related]
10. Splicing of a myosin phosphatase targeting subunit 1 alternative exon is regulated by intronic cis-elements and a novel bipartite exonic enhancer/silencer element.
Dirksen WP; Mohamed SA; Fisher SA
J Biol Chem; 2003 Mar; 278(11):9722-32. PubMed ID: 12509424
[TBL] [Abstract][Full Text] [Related]
11. Differentiation-specific alternative splicing of bovine papillomavirus late mRNAs.
Barksdale S; Baker CC
J Virol; 1995 Oct; 69(10):6553-6. PubMed ID: 7666558
[TBL] [Abstract][Full Text] [Related]
12. Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.
Bourgeois CF; Popielarz M; Hildwein G; Stevenin J
Mol Cell Biol; 1999 Nov; 19(11):7347-56. PubMed ID: 10523623
[TBL] [Abstract][Full Text] [Related]
13. CA- and purine-rich elements form a novel bipartite exon enhancer which governs inclusion of the minute virus of mice NS2-specific exon in both singly and doubly spliced mRNAs.
Gersappe A; Pintel DJ
Mol Cell Biol; 1999 Jan; 19(1):364-75. PubMed ID: 9858560
[TBL] [Abstract][Full Text] [Related]
14. Conserved RNA cis-elements regulate alternative splicing of Lepidopteran doublesex.
Wang XY; Zheng ZZ; Song HS; Xu YZ
Insect Biochem Mol Biol; 2014 Jan; 44():1-11. PubMed ID: 24239545
[TBL] [Abstract][Full Text] [Related]
15. Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions.
Furth PA; Choe WT; Rex JH; Byrne JC; Baker CC
Mol Cell Biol; 1994 Aug; 14(8):5278-89. PubMed ID: 8035806
[TBL] [Abstract][Full Text] [Related]
16. Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene.
Zhao X; Rush M; Schwartz S
J Virol; 2004 Oct; 78(20):10888-905. PubMed ID: 15452209
[TBL] [Abstract][Full Text] [Related]
17. A purine-rich element in foamy virus pol regulates env splicing and gag/pol expression.
Moschall R; Denk S; Erkelenz S; Schenk C; Schaal H; Bodem J
Retrovirology; 2017 Feb; 14(1):10. PubMed ID: 28166800
[TBL] [Abstract][Full Text] [Related]
18. Serine/Arginine-Rich Splicing Factor 3 and Heterogeneous Nuclear Ribonucleoprotein A1 Regulate Alternative RNA Splicing and Gene Expression of Human Papillomavirus 18 through Two Functionally Distinguishable cis Elements.
Ajiro M; Tang S; Doorbar J; Zheng ZM
J Virol; 2016 Oct; 90(20):9138-52. PubMed ID: 27489271
[TBL] [Abstract][Full Text] [Related]
19. A purine-rich intronic element enhances alternative splicing of thyroid hormone receptor mRNA.
Hastings ML; Wilson CM; Munroe SH
RNA; 2001 Jun; 7(6):859-74. PubMed ID: 11421362
[TBL] [Abstract][Full Text] [Related]
20. RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element.
Bilodeau PS; Domsic JK; Mayeda A; Krainer AR; Stoltzfus CM
J Virol; 2001 Sep; 75(18):8487-97. PubMed ID: 11507194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
